(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,
6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]
oxy-6-(hydroxymethyl)oxane-3,5-diol

상품명칭:	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S, 6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl] oxy-6-(hydroxymethyl)oxane-3,5-diol
CAS 레지스트리 번호:	49842-07-1
EINECS:	256-499-2
동의어:	Nebicina; Tobramycin sulphate;sulfuric acid;(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S, 6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl] oxy-6-(hydroxymethyl)oxane-3,5-diol; Gernebcin; 1-Epitobramycin sulfate; Obracine; EINECS 256-499-2;TOBRAMYCIN SULFATE; Tobra; Tenemicin; Nebcin;
분자 구조:
분자식:	C₁₈H₃₉N₅O₁₃S
분자량:	565.59296
밀도:	1.52g/cm³
비등점:	775.4°Cat760mmHg
인화점:	422.8°C
위험 코드:	61-20/21/22
안전 문장:	Poison by intravenous and intraperitoneal routes. Moderately toxic by subcutaneous route. Human systemic effects by intravenous route: wakefulness and hallucinations and distorted perceptions. When heated to decomposition it emits very toxic fumes of NOx and SOx. See also TOBRAMYCIN and SULFATES.
위험 기호:	T: Toxic;

(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol